We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

Washington’s Cannabis Regulator Seeks Scientists

Washington’s state cannabis regulator is looking to recruit at least six experts in cannabis science to help advise the regulator on scientific matters.

Read More

Trulieve Employee Died From Inhaling Cannabis Dust, Report Says

An employee at a cannabis cultivation facility in Holyoke, Massachusetts, died in January after inhaling “ground cannabis dust”, according to an inspection.

Read More

Psychedelics Sector Must Respect Indigenous Wisdoms, Say Experts

The new essay highlights numerous ethical concerns currently facing the field and emphasizes the importance of acknowledging wisdoms already known to Indigenous people.

Read More

Vermont Opens Its First Recreational Cannabis Dispensaries

On October 1, three dispensaries in the state began selling adult-use marijuana to long lines of eager customers.

Read More

Ultrasound-Assisted Extraction is Ideal to Prepare Solid Edibles For Testing, Study Finds

Use ultrasound-assisted extraction to prepare solid edibles for analysis, and use solid-phase extraction for beverages, scientists recommend.

Read More

Nevada Testing Lab May Lose License For Microbial Contaminants and Altered THC Results

The prediction follows a decision of Nevada’s Cannabis Compliance Board on Tuesday, September 27, to deny the lab’s motion to dismiss the case.

Read More

Ketamine Can Treat Depression By Altering a Person’s Beliefs, Study Suggests

Ketamine can help people with treatment-resistant depression by breaking their entrenched belief systems, according to a recent paper.

Read More

Medical Cannabis Weans Patients Off Opioids, Study Finds

A majority of participants (90.7%) who had been taking opioids and other pain medications were able to stop taking them or reduce their use.

Read More

Three Medical Cannabis Companies Fined in Australia For Advertising Products as Cancer and Epilepsy Treatments

Three medical cannabis companies have received fines that total almost $1 million (Australian dollars) from Australia’s drugs regulator.

Read More

 
Advertisement